DE69332480D1 - Impfstoff-vektoren von rekombinantem katzen-herpesvirus - Google Patents

Impfstoff-vektoren von rekombinantem katzen-herpesvirus

Info

Publication number: DE69332480D1
Authority: DE; Germany
Prior art keywords: fhv; vaccine vectors; herpesvirus; mutant; recombinant
Prior art date: 1992-07-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69332480T

Other languages

English (en)

Other versions

DE69332480T2 (de

Inventor

Paulus Jacobus An Sondermeijer

Martha Jacoba Willemse

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Akzo Nobel NV

Original Assignee

Akzo Nobel NV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-30

Filing date

1993-07-23

Publication date

2002-12-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69332480(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-07-23 Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV

2002-12-19 Application granted granted Critical

2002-12-19 Publication of DE69332480D1 publication Critical patent/DE69332480D1/de

2003-07-17 Publication of DE69332480T2 publication Critical patent/DE69332480T2/de

2013-07-24 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compression Or Coding Systems Of Tv Signals (AREA)
Peptides Or Proteins (AREA)

DE69332480T 1992-07-30 1993-07-23 Impfstoff-vektoren von rekombinantem katzen-herpesvirus Expired - Fee Related DE69332480T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP92202365		1992-07-30
PCT/EP1993/001971 WO1994003621A1 (en)	1992-07-30	1993-07-23	Vector vaccines of recombinant feline herpesvirus

Publications (2)

Publication Number	Publication Date
DE69332480D1 true DE69332480D1 (de)	2002-12-19
DE69332480T2 DE69332480T2 (de)	2003-07-17

Family

ID=8210815

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69332480T Expired - Fee Related DE69332480T2 (de)	1992-07-30	1993-07-23	Impfstoff-vektoren von rekombinantem katzen-herpesvirus

Country Status (10)

Country	Link
US (1)	US6521236B1 (de)
EP (1)	EP0606452B1 (de)
JP (1)	JP3529134B2 (de)
AT (1)	ATE227775T1 (de)
AU (1)	AU4702293A (de)
DE (1)	DE69332480T2 (de)
DK (1)	DK0606452T3 (de)
ES (1)	ES2187508T3 (de)
PT (1)	PT606452E (de)
WO (1)	WO1994003621A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995000172A1 (en) *	1993-06-24	1995-01-05	Michigan State University	Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof
DE69535125T2 (de) *	1994-04-29	2007-08-30	Pharmacia & Upjohn Co. Llc, Kalamazoo	Impfstoff gegen felines immunodefizienz-virus
FR2741806B1 (fr) *	1995-11-30	1998-02-20	Rhone Merieux	Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
US6231863B1 (en)	1997-06-10	2001-05-15	American Cyanamid Company	DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US7279168B2 (en)	1998-05-01	2007-10-09	Texas A & M University System	Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
WO1999057295A1 (en) *	1998-05-01	1999-11-11	Schering-Plough Ltd.	Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
JP2002112770A (ja)	2000-10-05	2002-04-16	Kyoritsu Seiyaku Kk	新規組換えネコヘルペスウイルス１型およびこれを用いた多価ワクチン
WO2009051823A2 (en) *	2007-10-18	2009-04-23	Michigan State University	Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU591145B2 (en) *	1985-07-29	1989-11-30	Pharmacia & Upjohn Company	Virus vaccine with deletion of an antigen of the wild-type virus
US5223424A (en) *	1985-09-06	1993-06-29	Prutech Research And Development	Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
AU623333B2 (en) *	1986-01-27	1992-05-14	Syntro Corporation	Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
US5324664A (en) *	1988-08-08	1994-06-28	The Upjohn Company	Herpes virus thymidien kinase-encoding DNA
DE69016956T2 (de) *	1989-12-04	1995-07-20	Akzo Nobel Nv	Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
FR2666589B1 (fr) *	1990-09-07	1994-08-05	Rhone Merieux	Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
WO1995000172A1 (en)	1993-06-24	1995-01-05	Michigan State University	Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof

1993
- 1993-07-23 JP JP50495894A patent/JP3529134B2/ja not_active Expired - Fee Related
- 1993-07-23 AT AT93917639T patent/ATE227775T1/de not_active IP Right Cessation
- 1993-07-23 PT PT93917639T patent/PT606452E/pt unknown
- 1993-07-23 WO PCT/EP1993/001971 patent/WO1994003621A1/en active IP Right Grant
- 1993-07-23 ES ES93917639T patent/ES2187508T3/es not_active Expired - Lifetime
- 1993-07-23 EP EP93917639A patent/EP0606452B1/de not_active Expired - Lifetime
- 1993-07-23 DE DE69332480T patent/DE69332480T2/de not_active Expired - Fee Related
- 1993-07-23 AU AU47022/93A patent/AU4702293A/en not_active Abandoned
- 1993-07-23 DK DK93917639T patent/DK0606452T3/da active
1995
- 1995-07-20 US US08/504,617 patent/US6521236B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69332480T2 (de)	2003-07-17
EP0606452B1 (de)	2002-11-13
WO1994003621A1 (en)	1994-02-17
EP0606452A1 (de)	1994-07-20
AU4702293A (en)	1994-03-03
DK0606452T3 (da)	2003-03-17
JP3529134B2 (ja)	2004-05-24
PT606452E (pt)	2003-03-31
ATE227775T1 (de)	2002-11-15
JPH06511392A (ja)	1994-12-22
ES2187508T3 (es)	2003-06-16
US6521236B1 (en)	2003-02-18

Publication	Publication Date	Title
CA2031164A1 (en)	1991-06-05	Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
CA2161962A1 (en)	1994-12-22	Adenovirus vectors for gene therapy
EP0596979A4 (en)	1994-07-13	Recombinant plant viral nucleic acids.
HK153395A (en)	1995-10-06	Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor
MX9800025A (es)	1998-03-31	Virus mva recombinante, y su empleo.
EP0776361A4 (de)	2003-06-04	Rekombinantes herpesvirus aus trufhähnen und seine verwendungen
EP0759935A4 (de)	1999-07-07	Rekombinanter papillomavirus l1
WO2000003030A3 (en)	2000-07-20	Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
DE69332480D1 (de)	2002-12-19	Impfstoff-vektoren von rekombinantem katzen-herpesvirus
DE69332393D1 (de)	2002-11-21	Rekombinanter Katzen-Herpesvirus-Impfstoff
DK0632129T3 (da)	2003-08-04	Rekombinante foamy-virusvektorer til medicinsk og diagnostisk anvendelse, og fremgangsmåder til at præparere rekombinante foamy-virusvektorer
AU4334193A (en)	1994-01-24	Infectious bovine rhinotracheitis virus mutants and vaccines
NZ508892A (en)	2004-02-27	Nucleic acid encoding a vaccine-induced mutant major surface antigen of a hepatitis B viral strain
HUT69793A (en)	1995-09-28	Recombinant adenovirus vaccines
AU1624292A (en)	1993-03-11	Recombinant vaccine against marek's disease
EP0774513A4 (de)	1999-10-13	REKOMBINANTES HERPESVIRUS UNTER DER VERWENDUNG DES gB GENPROMOTERS
EP0623172A4 (de)	1995-08-09	Rekombinanter poxvirus als impfstoff gegen der virus der marek-krankheit.
PT729509E (pt)	2004-09-30	Vacina contra papeira contendo uma estirpe do virus jerryl-lynn
MY118955A (en)	2005-02-28	Mutant human hepatitis b viral strain and uses thereof.
Keil	1999	Vector vaccines of bovine herpesvirus I
ES2074965A1 (es)	1995-09-16	Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
WO1994029472A3 (en)	1995-02-16	Mengovirus as a vector for expression of foreign polypeptides
MY157873A (en)	2016-07-29	Recombinant mva virus, and the use thereof

Legal Events

Date	Code	Title	Description
2003-12-11	8364	No opposition during term of opposition
2006-05-11	8339	Ceased/non-payment of the annual fee